Literature DB >> 16146428

Interaction with phospholipids modulates alpha-synuclein nitration and lipid-protein adduct formation.

Andrés Trostchansky1, Summer Lind, Roberto Hodara, Tomoyuki Oe, Ian A Blair, Harry Ischiropoulos, Homero Rubbo, José M Souza.   

Abstract

Intracellular aggregates of alpha-syn (alpha-synuclein) represent pathoanatomical hallmarks of neurodegenerative disorders (synucleinopathies). The molecular mechanisms underlying alpha-syn aggregation into filamentous inclusions may involve oxidation and nitration of the protein. Whereas the effects of oxidants and nitrating species on soluble alpha-syn have been studied in detail, the effect of these reactive species on alpha-syn associated with lipids is still unknown. In the present paper, we report that alpha-syn bound to small unilamellar liposomes composed of phosphatidylcholine/phosphatidic acid is resistant to oxidation and nitration when compared with soluble alpha-syn. Additionally, increasing concentrations of unsaturated fatty acids diminished the oxidation and nitration of alpha-syn upon exposure to fluxes of peroxynitrite (8-20 microM x min(-1)). To investigate the effect of oxidized lipids on alpha-syn, the protein was incubated with the bifunctional electrophile 4-HNE [4-hydroxy-2(E)-nonenal]. MS analysis showed the formation of three major products corresponding to the native protein and alpha-syn plus one or two 4-HNE molecules. Trypsin digestion of the modified protein followed by peptide 'finger-printing' revealed that 4-HNE modified the peptide E46GVVHGVATVAEK58. Further analysis of the peptides with liquid chromatography-tandem MS identified the modified residue as His50. The data indicate that the association of alpha-syn with biological membranes protects the protein from oxidation and nitration and thus diminishes the formation of protein molecules capable of forming aggregates. However, products of lipid peroxidation can also modify alpha-syn, generating novel protein adducts that could serve as biomarkers for documenting oxidative processes in human as well as animal and cellular models of alpha-syn aggregation and pathology.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16146428      PMCID: PMC1383693          DOI: 10.1042/BJ20051277

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  26 in total

1.  Reversible inhibition of alpha-synuclein fibrillization by dopaminochrome-mediated conformational alterations.

Authors:  Erin H Norris; Benoit I Giasson; Roberto Hodara; Shaohua Xu; John Q Trojanowski; Harry Ischiropoulos; Virginia M-Y Lee
Journal:  J Biol Chem       Date:  2005-04-06       Impact factor: 5.157

2.  Dityrosine cross-linking promotes formation of stable alpha -synuclein polymers. Implication of nitrative and oxidative stress in the pathogenesis of neurodegenerative synucleinopathies.

Authors:  J M Souza; B I Giasson; Q Chen; V M Lee; H Ischiropoulos
Journal:  J Biol Chem       Date:  2000-06-16       Impact factor: 5.157

3.  Crosslinking of alpha-synuclein by advanced glycation endproducts--an early pathophysiological step in Lewy body formation?

Authors:  G Münch; H J Lüth; A Wong; T Arendt; E Hirsch; R Ravid; P Riederer
Journal:  J Chem Neuroanat       Date:  2000-12       Impact factor: 3.052

4.  Exposure to long chain polyunsaturated fatty acids triggers rapid multimerization of synucleins.

Authors:  R J Perrin; W S Woods; D F Clayton; J M George
Journal:  J Biol Chem       Date:  2001-09-11       Impact factor: 5.157

5.  Formation of lipid-protein adducts in low-density lipoprotein by fluxes of peroxynitrite and its inhibition by nitric oxide.

Authors:  A Trostchansky; C Batthyány; H Botti; R Radi; A Denicola; H Rubbo
Journal:  Arch Biochem Biophys       Date:  2001-11-15       Impact factor: 4.013

6.  Interaction of human alpha-Synuclein and Parkinson's disease variants with phospholipids. Structural analysis using site-directed mutagenesis.

Authors:  R J Perrin; W S Woods; D F Clayton; J M George
Journal:  J Biol Chem       Date:  2000-11-03       Impact factor: 5.157

7.  alpha-Synuclein membrane interactions and lipid specificity.

Authors:  E Jo; J McLaurin; C M Yip; P St George-Hyslop; P E Fraser
Journal:  J Biol Chem       Date:  2000-11-03       Impact factor: 5.157

8.  Widespread nitration of pathological inclusions in neurodegenerative synucleinopathies.

Authors:  J E Duda; B I Giasson; Q Chen; T L Gur; H I Hurtig; M B Stern; S M Gollomp; H Ischiropoulos; V M Lee; J Q Trojanowski
Journal:  Am J Pathol       Date:  2000-11       Impact factor: 4.307

9.  Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions.

Authors:  B I Giasson; J E Duda; I V Murray; Q Chen; J M Souza; H I Hurtig; H Ischiropoulos; J Q Trojanowski; V M Lee
Journal:  Science       Date:  2000-11-03       Impact factor: 47.728

10.  Induction of alpha-synuclein aggregation by intracellular nitrative insult.

Authors:  E Paxinou; Q Chen; M Weisse; B I Giasson; E H Norris; S M Rueter; J Q Trojanowski; V M Lee; H Ischiropoulos
Journal:  J Neurosci       Date:  2001-10-15       Impact factor: 6.167

View more
  9 in total

Review 1.  Signaling by 4-hydroxy-2-nonenal: Exposure protocols, target selectivity and degradation.

Authors:  Hongqiao Zhang; Henry Jay Forman
Journal:  Arch Biochem Biophys       Date:  2016-11-10       Impact factor: 4.013

2.  Modulation of lipid peroxidation and mitochondrial function improves neuropathology in Huntington's disease mice.

Authors:  Junghee Lee; Bela Kosaras; Steve J Del Signore; Kerry Cormier; Ann McKee; Rajiv R Ratan; Neil W Kowall; Hoon Ryu
Journal:  Acta Neuropathol       Date:  2010-12-16       Impact factor: 17.088

Review 3.  Nitric oxide and peroxynitrite in health and disease.

Authors:  Pál Pacher; Joseph S Beckman; Lucas Liaudet
Journal:  Physiol Rev       Date:  2007-01       Impact factor: 37.312

4.  Lipid peroxidation product 4-hydroxy-2-nonenal promotes seeding-capable oligomer formation and cell-to-cell transfer of α-synuclein.

Authors:  Eun-Jin Bae; Dong-Hwan Ho; Eunbi Park; Jin Woo Jung; Kyungcho Cho; Ji Hye Hong; He-Jin Lee; Kwang Pyo Kim; Seung-Jae Lee
Journal:  Antioxid Redox Signal       Date:  2012-09-26       Impact factor: 8.401

5.  In parkinsonian substantia nigra, alpha-synuclein is modified by acrolein, a lipid-peroxidation product, and accumulates in the dopamine neurons with inhibition of proteasome activity.

Authors:  M Shamoto-Nagai; W Maruyama; Y Hashizume; M Yoshida; T Osawa; P Riederer; M Naoi
Journal:  J Neural Transm (Vienna)       Date:  2007-08-10       Impact factor: 3.575

6.  α-Synuclein structural features inhibit harmful polyunsaturated fatty acid oxidation, suggesting roles in neuroprotection.

Authors:  Giorgia De Franceschi; Chiara Fecchio; Ronit Sharon; Anthony H V Schapira; Christos Proukakis; Vittorio Bellotti; Patrizia Polverino de Laureto
Journal:  J Biol Chem       Date:  2017-02-23       Impact factor: 5.157

7.  Two conformationally distinct α-synuclein oligomers share common epitopes and the ability to impair long-term potentiation.

Authors:  Femke van Diggelen; Dean Hrle; Mihaela Apetri; Gunna Christiansen; Gerhard Rammes; Armand Tepper; Daniel Erik Otzen
Journal:  PLoS One       Date:  2019-03-22       Impact factor: 3.240

Review 8.  Modulation of the Interactions Between α-Synuclein and Lipid Membranes by Post-translational Modifications.

Authors:  Rosie Bell; Michele Vendruscolo
Journal:  Front Neurol       Date:  2021-07-15       Impact factor: 4.003

Review 9.  Alpha-Synuclein Post-translational Modifications: Implications for Pathogenesis of Lewy Body Disorders.

Authors:  Nelson de Oliveira Manzanza; Lucia Sedlackova; Raj N Kalaria
Journal:  Front Aging Neurosci       Date:  2021-06-25       Impact factor: 5.750

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.